Blood tests shown to spot 'earliest' stages of Alzheimer's will 'revolutionise' diagnosis

Date:

Share post:

[ad_1]

However, over the six year period, it was shown that only phospho-tau217 (abbreviated to p-tau217) was related to Alzheimer’s disease pathology, a decline in cognitive performance and increased brain atrophy typical of incipient Alzheimer’s.

Scientists concluded that p-tau217 will be an “ideal” for the detection of relevant disease-modifying effects of novel interventions.

First study author, Doctor Nicholas Ashton from the University of Gothenburg, said: “Distinctive blood tests may be optimal for the identification of Alzheimer’s pathology or for monitoring of disease progression and therefore have different roles in clinical trials.

“This study has shown that p-tau217 is uniquely placed to be an optimal test for monitoring patients in both a clinical setting and a trial setting because of its longitudinal association with Alzheimer’s development.”

READ MORE: How to tell you’ve had a heart attack for a ‘few minutes’ without realising – the signs



[ad_2]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Related articles

Selena Gomez, 30, says ‘I’m a little big’ as she hits back at Golden Globe outfit trolls

Selena, 30, hit back at online trolls who wrote nasty comments about her weight, despite oozing confidence...

Dancing On Ice’s Ekin-Su details ‘supportive’ gestures from partner Davide

“It's great, I’m happy I’m doing it, no regrets at all, see you later to the curse!”Ekin...

Kate wore stunning full length gown with a trendy twist – shows off her enviable legs

The royal turned heads in a silver chain with lots of geometric shapes attached to it, and...

Nick Kyrgios risks trouble with Aussie police after scooter ride before Australian Open

Nick Kyrgios could find himself in hot water ahead of the Australian Open after he was pictured riding an e-scooter...